FindTrial
Sign In

Sclerosing epithelioid fibrosarcoma with initial presentation as pulmonary masses: clinicopathological characteristics and diagnostic challenges

Sclerosing epithelioid fibrosarcoma with initial presentation as pulmonary masses: clinicopathological characteristics and diagnostic challenges

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129715
Enrollment
Unknown
Registered
2026-08-08
Start date
2026-08-15
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sclerosing epithelioid fibrosarcoma

Interventions

Patients with sclerosing epithelioid fibrosarcoma:None

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Pulmonary cases definitively diagnosed as sclerosing epithelioid fibrosarcoma.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Pathological Characteristics ;—

Secondary

MeasureTime frame
Clinical and Imaging Features;Prognosis;—

Countries

China

Contacts

Public ContactGuang-Jie Duan

The First Affiliated Hospital of Army Medical University

gjduan@163.com+86 23 68766643

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026